InvestorsHub Logo
Followers 24
Posts 700
Boards Moderated 0
Alias Born 05/17/2013

Re: frosr6 post# 33445

Sunday, 03/29/2015 9:19:19 AM

Sunday, March 29, 2015 9:19:19 AM

Post# of 144811
Interesting points you made Frosr6....

What are your opinions regarding the collaborative effort between TD2 & Nuvilex (PharmaCyte)? Is it all smoke and mirrors? If yes, why would Van Hoff associate his name and TD2 with this? Perhaps PharmaCyte is just using TD2 as a conduit to conduct clinical trials and Hoff has no idea whether CIB will work or not? It appears that Nuvilex/PharmaCyte has been at this for a looooong time now. Big Pharma can be extremely aggressive in their acquisitions if they believe a product will work. Some will even buy before any results from clinical trials. Pipelines are getting more and more thin at these major pharmas; hence the aggressive acquisitions or potential takeovers of late.


TD2 and Dr. Von Hoff will play a pivotal role in the development of our treatment for patients with advanced pancreatic cancer that combines the proprietary Cell-in-a-Box live-cell encapsulation technology with the cancer drug ifosfamide

http://www.td2inc.com/news/nuvilex-selects-translational-drug-development-td2-to-advanc


I will say this, the more paid promotions from these nefarious junky ass articles/news sources and constant PR's that happen every week, the less likely I will invest in this company. I would like to see a recent PR from TD2 from a highly credible news source.

Still way too many red flags here.

We will see.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News